JOHNS HOPKINS UNIVERSITY

🇳🇦Namibia

Country: 🇳🇦Namibia

Ownership: -

Established: 1876-01-01

Employees: 19.4K

Market Cap: -

Website: https://www.jhu.edu/

Clinical Trials

Sleep Disruption in Post-operative Patients in the Neurocritical Care Unit

Not Applicable

Terminated

Conditions: Sleep Fragmentation

Interventions: Behavioral: sleep disruption

First Posted Date: 2016-12-20

Last Posted Date: 2018-04-03

Lead Sponsor: Johns Hopkins University

Target Recruit Count: 1

Registration Number: NCT02997839

Locations: 🇺🇸
Johns Hopkins, Baltimore, Maryland, United States

Fractional Laser Assisted Steroid Therapy vs Intralesional Steroids in the Treatment of Keloids

Not Applicable

Completed

Conditions: Keloid

Interventions: Drug: Intralesional Triamcinolone Acetonide
Device: The Lutronic electronic carbon dioxide (eCO2) Plus laser system

First Posted Date: 2016-12-19

Last Posted Date: 2020-12-17

Lead Sponsor: Johns Hopkins University

Target Recruit Count: 30

Registration Number: NCT02996097

Locations: 🇺🇸
Johns Hopkins School of Medicine, Department of Dermatology, Baltimore, Maryland, United States

The Utility of Thromboelastography in Cirrhotic Patients Undergoing Endoscopic Procedures

Not Applicable

Terminated

Conditions: Cirrhosis, Coagulopathy

Interventions: Biological: Blood transfusion

First Posted Date: 2016-12-13

Last Posted Date: 2021-01-22

Lead Sponsor: Johns Hopkins University

Target Recruit Count: 1

Registration Number: NCT02990273

INIA Stress and Chronic Alcohol Interactions: Glucocorticoid Antagonists in Heavy Drinkers

Phase 1

Completed

Conditions: Alcohol Use Disorder

Interventions: Drug: Mifepristone
Drug: Placebo - Cap

First Posted Date: 2016-12-12

Last Posted Date: 2025-05-30

Lead Sponsor: Johns Hopkins University

Target Recruit Count: 65

Registration Number: NCT02989662

Locations: 🇺🇸
Integrated Program for Substance Abuse Research, Baltimore, Maryland, United States

Intranasal Insulin for Improving Cognitive Function in Multiple Sclerosis

Phase 1

Completed

Conditions: Multiple Sclerosis, Relapsing-Remitting
Multiple Sclerosis, Secondary Progressive
Multiple Sclerosis, Primary Progressive

Interventions: Drug: Insulin
Drug: Placebo (Sterile diluent)

First Posted Date: 2016-12-09

Last Posted Date: 2023-03-10

Lead Sponsor: Johns Hopkins University

Target Recruit Count: 105

Registration Number: NCT02988401

Locations: 🇺🇸
Johns Hopkins University School of Medicine, Baltimore, Maryland, United States

Clinical Applications of Contrast-Enhanced Ultrasonography in Pediatric Population - Intravesicle Administration

Not Applicable

Withdrawn

Conditions: Vesico-Ureteral Reflux

Interventions: Other: Contrast Ultrasound

First Posted Date: 2016-12-08

Last Posted Date: 2018-01-25

Lead Sponsor: Johns Hopkins University

Registration Number: NCT02986477

An Observational Study of the Use of Chloral Hydrate for Ophthalmic Procedures in Children

Completed

Conditions: Anesthesia
Intraocular Pressure

Interventions: Other: Intraocular pressure evaluation

First Posted Date: 2016-12-07

Last Posted Date: 2016-12-07

Lead Sponsor: Johns Hopkins University

Target Recruit Count: 324

Registration Number: NCT02985567

Locations: 🇸🇦
King Khaled Eye Specialist Hospital (KKESH), Riyadh, Saudi Arabia

Olanzapine for the Treatment of Refractory Chronic Nausea and Vomiting

Withdrawn

Conditions: Vomiting
Nausea

First Posted Date: 2016-11-30

Last Posted Date: 2018-08-20

Lead Sponsor: Johns Hopkins University

Registration Number: NCT02977741

Locations: 🇺🇸
Johns Hopkins University, Baltimore, Maryland, United States

Changes in Biomarkers From Blood Over Time in Patients With Pancreatic Adenocarcinoma

Completed

Conditions: Pancreatic Cancer
Biological Markers
Neoplastic Cells, Circulating

Interventions: Other: No intervention/exposures

First Posted Date: 2016-11-28

Last Posted Date: 2019-01-24

Lead Sponsor: Johns Hopkins University

Target Recruit Count: 200

Registration Number: NCT02974764

Locations: 🇺🇸
Johns Hopkins University, Baltimore, Maryland, United States

Persisting Effects of Psilocybin

Phase 1

Completed

Conditions: Healthy

Interventions: Drug: Psilocybin

First Posted Date: 2016-11-23

Last Posted Date: 2019-09-10

Lead Sponsor: Johns Hopkins University

Target Recruit Count: 13

Registration Number: NCT02971605

Locations: 🇺🇸
Behavioral Pharmacology Research Unit, Johns Hopkins Bayview Medical Center, Baltimore, Maryland, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy